Viewing data from:

METHYLDOPA

ANDA

METHYLDOPA | A070076 | RISING PHARMA HOLDING INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$7.50

per ea

Lowest NADAC/Unit

$7.50

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980057101METHYLDOPA 250 MG TABLET	$7.50	EA	Generic	—	2025-08-27

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs5 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

ZHEJIANG CHIRAL MEDICINE CHEMICALS CO LTDMETHYLDOPA

DMF 205652007

ZHEJIANG WILD WIND PHARMACEUTICAL CO LTDMETHYLDOPA (NON-STERILE, BULK FORM)

DMF 224252008

TAPI NL BVMETHYLDOPA

DMF 267262013

ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTDMETHYLDOPA

DMF 428292025

ANTIBIOTICOS SPAInactiveMETHYLDOPA USP

DMF 26961976

PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKSInactiveMETHYLDOPA USP

DMF 32431978

ACIC LTDInactiveMETHYLDOPA USP

DMF 34721979

FARCHEMIA SRLInactiveMETHYLDOPA

DMF 61401985

DIVIS LABORATORIES LTDInactiveMETHYLDOPA USP

DMF 176992004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 18, 1985

No patent or exclusivity listings for this strength.

#002 — 250MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 18, 1985